Seksuelle bivirkninger ved SSRI
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Dokumenter
- Fulltext
Forlagets udgivne version, 434 KB, PDF-dokument
Treatment with SSRI have a high frequency of treatment of emergent sexual dysfunction. The mechanism is thought to be through serotoninergic inhibition of the sexual response. More than 70% of patients treated with sertraline, citalopram or paroxetine experience sexual side effects, while escitalopram and fluvoxamine yield the lowest degree of sexual dysfunction within the group. This review suggests management strategies including dose reduction, change of medication and add-on treatment. A small group of patients experience post-SSRI dysfunction, in which sexual dysfunction persists after treatment termination.
Bidragets oversatte titel | Sexual side effects from treatment with SSRI |
---|---|
Originalsprog | Dansk |
Artikelnummer | V11210824 |
Tidsskrift | Ugeskrift for Laeger |
Vol/bind | 184 |
Udgave nummer | 14 |
Antal sider | 9 |
ISSN | 0041-5782 |
Status | Udgivet - 4 apr. 2022 |
- Citalopram/adverse effects, Humans, Paroxetine/adverse effects, Serotonin Uptake Inhibitors/adverse effects, Sertraline/adverse effects, Sexual Dysfunction, Physiological/chemically induced
Forskningsområder
Links
- https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2022-03/v11210824_web.pdf
Forlagets udgivne version
Antal downloads er baseret på statistik fra Google Scholar og www.ku.dk
ID: 325710971